Identifying Vaginal Atrophy in a 73-Year-Old Woman
Vaginal atrophy (now termed genitourinary syndrome of menopause/GSM) is identified through a combination of characteristic symptoms (burning, itching, dysuria, vaginal dryness) plus visual inspection findings on genitourinary examination showing decreased moisture, loss of vaginal rugae, vaginal pallor/erythema, and tissue fragility, along with vaginal pH >5. 1
Diagnostic Approach
Step 1: Focused History
Query specifically about:
- Genital symptoms: Vaginal dryness, burning, itching, irritation
- Urinary symptoms: Dysuria, urgency, frequency, nocturia, recurrent UTIs
- Sexual symptoms: Dyspareunia, decreased lubrication, post-coital bleeding 1
Important caveat: In this 73-year-old woman with recent antibiotic use, you must differentiate between vaginal atrophy and infectious vaginitis, as symptoms overlap significantly. The recent antibiotic course raises suspicion for candidiasis or bacterial vaginosis.
Step 2: Genitourinary Examination
All patients with suspected GSM should undergo genitourinary examination 1. Prior to examination, obtain informed consent and offer a chaperone, using trauma-informed care principles.
Visual Inspection Findings Indicating Atrophy:
- Decreased vaginal moisture (most common sign, 60% prevalence) 2
- Loss of vaginal rugae (54-90% prevalence depending on years since menopause) 3
- Vaginal pallor or erythema (47-90% prevalence) 3
- Tissue fragility with petechiae or fissures (15-51% prevalence) 2, 3
- Introital stenosis and retraction
- Loss of hymenal remnants
- Urethral changes: Meatal prominence, caruncles, urethral prolapse 1
Step 3: Objective Testing
Measure vaginal pH: pH >5 supports the diagnosis of vaginal atrophy 2, 4. This is critical because:
- Normal premenopausal pH is 3.5-4.5
- Atrophic vaginal pH typically exceeds 5
- pH >5 was present in 78-90% of postmenopausal women with atrophy 3
However, pH >5 can also indicate infection, which is particularly relevant given this patient's recent antibiotic use and symptoms.
Critical Diagnostic Considerations
Rule Out Coexisting Conditions
The guideline explicitly states you must assess for conditions that mimic GSM 1:
- Vaginitis (bacterial vaginosis, candidiasis) - especially likely given recent antibiotics
- UTI - given dysuria presentation
- Dermatitis or dermatoses
- Malignancy - always inspect for in this age group
The Diagnostic Challenge
There is poor correlation between subjective symptoms and objective signs of vaginal atrophy 3. The only exception is subjective versus objective vaginal dryness, which correlate well (sensitivity 0.96, specificity 0.82). This means you cannot diagnose based on symptoms alone - examination is mandatory.
Algorithmic Approach for This Patient
- Perform genitourinary examination looking for the atrophic signs listed above
- Measure vaginal pH (if >5, supports atrophy OR infection)
- Obtain wet mount/culture to rule out infectious vaginitis given recent antibiotic use
- Urinalysis to rule out UTI given dysuria
If examination shows atrophic changes (pallor, loss of rugae, decreased moisture, tissue fragility) AND pH >5 AND cultures are negative, the diagnosis is vaginal atrophy 1, 4.
If cultures are positive, treat the infection first, then reassess for persistent atrophic changes that would indicate coexisting GSM requiring separate treatment.
Common Pitfalls
- Assuming all genitourinary symptoms in postmenopausal women are due to atrophy: This patient's recent antibiotic use makes infection highly likely as a contributing or primary cause
- Relying on symptoms alone: Examination findings are essential for diagnosis 1
- Missing coexisting conditions: Up to 45% of postmenopausal women have vaginal atrophy 5, but they can simultaneously have infections or other pathology
- Not measuring pH: This simple objective measure significantly aids diagnosis 4